Clinical_Rounds_in_Endocrinology_Volume_II_-_Pediatric_Endocrinology

(singke) #1

166



  1. What are the adjuvant therapies in XLH?


Recombinant growth hormone has been tried to increase phosphate reabsorp-
tion in patients with X-linked hypophosphatemic rickets/osteomalacia; how-
ever, it has not been found to be beneficial. Calcimimetic agents like cinacalcet
have been used to treat secondary hyperparathyroidism associated with phos-
phate therapy. Use of cinacalcet has been shown to be effective in reducing the
doses of phosphate and calcitriol. Recently, use of intravenous iron therapy has
also been shown to be useful. Monoclonal antibodies against FGF-23 have been
shown to be effective in mouse models of X-linked hypophosphatemia.


  1. What are the endocrine manifestations of renal tubular acidosis?


Renal tubular acidosis (RTA) is characterized by normal anion gap metabolic
acidosis with hypokalemia in the presence of normal glomerular filtration rate.
RTA may occur either due to the defect in reabsorption of HCO 3 - at proximal
tubule (proximal RTA, type 2) or defect in excretion of H+ ions at distal tubule
(distal RTA, type 1). The endocrine manifestations of RTA include growth fail-
ure, polyuria, rickets–osteomalacia, and nephrocalcinosis–nephrolithiasis. In
addition, type 4 RTA is characterized by normal anion gap metabolic acidosis
with hyperkalemia and normal or modestly reduced glomerular filtration rate.


  1. What are the differences in clinical features of proximal and distal RTA?


The characteristic clinical features of proximal and distal RTA are summarized
in the table given below.

Parameters

Proximal RTA Distal RTA
(Type 2) (Type 1)
Pathogenesis Defect in reabsorption of
HCO 3 − at proximal tubule of
kidney

Defect in excretion of H+ ions
at distal tubule of kidney

Growth failure Often present Often present
Rickets–osteomalacia Often present Often present
Nephrocalcinosis–
nephrolithiasis

Absent Often present

Other tubular defects Common (Fanconi’s syndrome) Absent
Etiology Primary Primary
Secondary: Secondary:
Wilson disease Sjogren’s syndrome
Valproate Systemic lupus
Aminoglycoside erythematosus
Acetazolamide


  1. Why is there rickets in RTA?


Rickets–osteomalacia is a characteristic feature of both proximal and distal RTA,
and the pathophysiological mechanisms for the development of rickets–osteoma-

5 Rickets–Osteomalacia
Free download pdf